A controlled double blind study of azathioprine in the management of Crohn's disease - Wikidata - awgldk - TriplyDB

A controlled double blind study of azathioprine in the management of Crohn's disease

A controlled double blind study of azathioprine in the management of Crohn's disease

http://www.wikidata.org/entity/Q34408881

about

Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal Use of thiopurines in inflammatory bowel disease Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity Health-related quality of life during natalizumab maintenance therapy for Crohn's disease Severe and steroid-resistant Crohn's disease New genetic biomarkers predicting azathioprine blood concentrations in combination therapy with 5-aminosalicylic acid Medical management of Crohn's disease: current therapy and recent advances.Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.Use of thiopurines in inflammatory bowel disease: Safety issues.Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.Conventional therapy for Crohn's disease Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis.Review article: the clinical role of anti-TNFalpha antibody treatment in Crohn's disease.Routine use of thiopurines in maintaining remission in pediatric Crohn's disease.Current status of thiopurine analogues in the treatment in Crohn's disease.Review article: the management of severe Crohn's disease.Predictors of recurrence of Crohn's disease after ileocolectomy: a review.Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine.Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn's disease Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Review article: monitoring for drug side-effects in inflammatory bowel disease.Role of conventional therapies in the era of biological treatment in Crohn's disease.What do I do in my practice that isn't evidence based?Infliximab therapy in pediatric Crohn's disease: a review.Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group Managing refractory Crohn's disease: challenges and solutions Azathioprine in inflammatory bowel disease, a safe alternative?

P2860

Q24186291-C89E592A-47F0-407E-9A91-2C925B18A2B8 Q24197676-F01D2FD6-7D78-46F3-9FDD-6A6189A9045F Q24240676-E9441FB1-1367-4C7C-8802-146EA96796F9 Q24616161-4F7CC9EE-2295-4838-831B-D59E89BBC22D Q26801119-1B1A55AF-5EE4-46B2-87BB-3BC7E3E881D6 Q26824662-FF948AD8-D68B-49FF-8927-10CE298769FF Q26996946-F0E45BFE-DB69-46FA-BF1E-DAF47FFD8B22 Q27008246-F32ABF17-9694-4E8E-ABAA-335E53B15F97 Q28079644-DA83BCDD-6928-4204-89A0-938C181B412F Q28115755-1FBB93B1-B1F0-414D-9DE7-97198E0F9B23 Q28258882-7A68E93A-8119-4A40-B38F-4929CDD6025B Q28266806-FB41DA7F-64FC-4FD3-ABFE-32B6D921A9BE Q28538238-51F73A9B-DC56-4D41-AE0C-495DBCE8C21F Q30450875-09E73A8A-F365-4E06-951D-D34CA9DC5E09 Q33393356-2BFC7A44-136F-4E1F-8CEE-D2B6668361E3 Q33621267-CCBF76C3-D3AE-4BEA-9892-E6E81C4071EA Q33696379-A2B912D4-B592-4160-A5AA-5ECED1072FDA Q33855714-B41CAB59-EEE4-4114-9F5B-8321CA955FF1 Q33866982-82B89B1A-8ED3-4FA3-AEE8-11238107CFF0 Q33879437-06453F0A-1E18-4C0F-9FA1-F558AFD911DC Q33890504-158768E7-5630-420F-95B6-B7701860ABE1 Q33904308-19ECB751-2387-4771-9FD9-3A75E7631446 Q33958703-DA7C7C5E-1687-41F4-9D92-2848E918C850 Q34235370-809B734C-A453-4DF9-A307-2334A1444B7D Q34235823-F81B1F75-C5A8-4B88-AE2A-DBD46F5E2D51 Q34366947-803A741C-E587-4BEC-9839-A81FB45F97CC Q34409942-E5A91ECD-F0F8-4182-B756-CC291595F195 Q34421471-C68E690B-3FAF-4649-BCD3-F710C8FA9D4D Q34449843-2ECDDB8F-A8C9-484F-96E9-CE699DBE0CDC Q34516280-A0B61F8C-282C-4BEC-9115-21AD60D90524 Q34559065-7E7C7C21-D8C7-4B94-ABD5-2F08FCAB55AE Q34564902-FA3FA4CC-8811-4EDB-8AAC-DFAE35696510 Q34585315-6741C4E4-C9AF-4ABD-9294-9D65F33251BC Q34831072-E09AC3DF-FDAC-45ED-BFB6-793F038D6157 Q35010169-A838DFE9-8BA4-4C55-B942-3FA6AFBAC592 Q35026358-71297A60-704B-49EF-AFF7-549328C64E37 Q35036160-24467942-DA12-461E-B3DD-9720D9531D67 Q35350179-2417FFE9-E7E7-4AA4-8EEF-84950562630D Q35460367-27C67E0F-397D-4CE2-8C4E-F942E0C3A199 Q35609845-F5B375E3-3540-486B-9351-C373D981EC56

P2860

A controlled double blind study of azathioprine in the management of Crohn's disease

http://www.wikidata.org/entity/Q34408881

description

1995 nî lūn-bûn

@nan

1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

A controlled double blind study of azathioprine in the management of Crohn's disease

@ast

A controlled double blind study of azathioprine in the management of Crohn's disease

@en

A controlled double blind study of azathioprine in the management of Crohn's disease

@nl

type

label

A controlled double blind study of azathioprine in the management of Crohn's disease

@ast

A controlled double blind study of azathioprine in the management of Crohn's disease

@en

A controlled double blind study of azathioprine in the management of Crohn's disease

@nl

prefLabel

A controlled double blind study of azathioprine in the management of Crohn's disease

@ast

A controlled double blind study of azathioprine in the management of Crohn's disease

@en

A controlled double blind study of azathioprine in the management of Crohn's disease

@nl

P1433

Q34408881-C1FB274E-1422-4F88-B2C6-E0CA7B058BB7

P1476

Q34408881-4774F441-2CDB-4B7C-8C95-486C09E6066C

P2093

Q34408881-742F2F8E-8586-4643-B3C3-7502539DF107

Q34408881-7D456E20-FA60-43F2-8107-E0B5A5698F56

Q34408881-8E0E838F-316F-446B-BA2F-E5696D0C8640

Q34408881-A4C318AF-11E8-4447-BE96-0929EE4B1560

Q34408881-A5D595E4-28AF-4818-ABCE-674DED1B562E

Q34408881-D9FF62E7-8F13-43AC-B5FE-429A5C294F54

P2860

Q34408881-2D8DA89D-B309-47B0-916C-950351DFFB20

Q34408881-4B155FA1-A5BC-400A-9EA0-2F58457EFDDF

Q34408881-7EA62C32-B3B6-4AA3-AE01-5C6F39C2ABD7

Q34408881-907D12FE-5D6F-490A-810E-70F3AA2A1F52

Q34408881-986A9CC3-31CC-42EB-B280-F1DAEC18C715

Q34408881-BC429D88-1886-466B-BA0E-B421364DAD58

Q34408881-D3788D9D-8F9D-4A44-91CD-12E09C19A053

Q34408881-DE3632D1-462B-40B2-B331-17622F2A15D1

Q34408881-E59DD849-DBCE-45B0-9E7E-BE74291ADB38

Q34408881-E8CBF629-8AC9-4B84-97AF-73E52DDC6D24

P304

Q34408881-17614B1A-AF30-450A-BC71-7EB978D3529E

P31

Q34408881-62D083F1-94D9-4CCD-9037-8F47D93CF804

P356

Q34408881-68030D16-F7CB-4E5D-987C-C169C04606CD

P407

Q34408881-3874F063-E909-40A2-B678-4EA79C8317C9

P433

Q34408881-7D4D1A82-0BF3-4A5A-AF51-E7DEA75ABE87

P478

Q34408881-C837034F-BFAA-4459-B88D-FE5C81942712

P577

Q34408881-DD977AC8-38E7-40D9-BF2B-7C8CC48C6D0A

P5875

Q34408881-FBD35534-220E-4F99-A5D3-20E1774891C5

P698

Q34408881-B76ABFD6-72A2-48F8-AC00-8545B58F0195

P921

Q34408881-5C65DA09-B938-4AF9-ABD6-404C3081699C

P932

Q34408881-BA0BA522-B16D-47DE-A09B-3F2CF78A31CD

P356

P1433

P1476

A controlled double blind study of azathioprine in the management of Crohn's disease

@en

P2093

Adams G

http://www.w3.org/2001/XMLSchema#string

Candy S

http://www.w3.org/2001/XMLSchema#string

Gerber M

http://www.w3.org/2001/XMLSchema#string

Gerig M

http://www.w3.org/2001/XMLSchema#string

Goodman R

http://www.w3.org/2001/XMLSchema#string

Wright J

http://www.w3.org/2001/XMLSchema#string

P2860

A controlled trial of azathioprine in Crohn's disease

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

A meta-analysis of the role of smoking in inflammatory bowel disease

Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease.

National Cooperative Crohn's Disease Study: results of drug treatment.

Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.

How effective are current drugs for Crohn's disease? A meta-analysis.

Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease.

Treatment of Crohn's disease with azathioprine: a controlled evaluation.

Controlled trial of azathioprine in Crohn's disease.

P304

674-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.37.5.674

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

1995-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14650470

http://www.w3.org/2001/XMLSchema#string

P698

8549944

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease

P932

1382873

http://www.w3.org/2001/XMLSchema#string